Can a simple pill prevent pancreatitis after ERCP? new study tests two drugs

NCT ID NCT06252441

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether taking oral N-Acetyl cysteine before an ERCP procedure could prevent pancreatitis as well as the standard treatment, rectal diclofenac. Forty-six adults at risk for pancreatitis after ERCP received one of the two drugs. The goal was to see which drug better reduces inflammation and prevents pancreatitis from developing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
N-Acetyl cysteine and diclofenac
What this could lead to
If it works, this could point toward a safer or more effective way to prevent pancreatitis after ERCP.
What could go wrong
This is a small, early-phase study with only 46 participants, so results may not apply to everyone. The drugs may not work as hoped or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST ERCP PANCREATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Obstructive Jaundice Clinic in the National Liver Institute, Menoufia University , Shebin Elkoom

    Menofia, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.